Publicaciones en colaboración con investigadores/as de KU Leuven (21)

2019

  1. PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas

    Blood, Vol. 133, Núm. 22, pp. 2401-2412

  2. Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia

    Blood, Vol. 134, Núm. 16, pp. 1323-1336

2018

  1. A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

    Haematologica, Vol. 103, Núm. 8, pp. 1351-1358

  2. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system

    Leukemia, Vol. 32, Núm. 4, pp. 941-951

  3. HOXA9 cooperates with activated JAK/STAT signaling to drive leukemia development

    Cancer Discovery, Vol. 8, Núm. 5, pp. 616-631

  4. Richter transformation driven by Epstein–Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia

    Journal of Pathology, Vol. 245, Núm. 1, pp. 61-73

  5. The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models

    Journal of Hematology and Oncology, Vol. 11, Núm. 1

  6. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling

    Leukemia, Vol. 32, Núm. 3, pp. 809-819

2017

  1. The genetics and molecular biology of T-ALL

    Blood, Vol. 129, Núm. 9, pp. 1113-1123

2016

  1. Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia

    Haematologica, Vol. 101, Núm. 8, pp. 951-958

  2. Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors

    Blood, Vol. 128, Núm. 23, pp. 2642-2654

  3. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

2015

  1. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia

    Haematologica, Vol. 100, Núm. 10, pp. 1301-1310

  2. The genomic landscape of adult T cell leukemia/lymphoma

    Nature Genetics

  3. The origin of relapse in pediatric T-cell acute lymphoblastic leukemia

    Haematologica

2014

  1. Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. BMI1, The polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma

    Genes Chromosomes and Cancer, Vol. 52, Núm. 10, pp. 928-944

  2. Downregulation of FOXP1 is required during germinal center B-cell function

    Blood, Vol. 121, Núm. 21, pp. 4311-4320

  3. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia

    Nature Genetics, Vol. 45, Núm. 2, pp. 186-190

  4. LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas

    British Journal of Haematology, Vol. 162, Núm. 5, pp. 621-630